| Followers | 96 |
| Posts | 5080 |
| Boards Moderated | 0 |
| Alias Born | 02/07/2021 |
Monday, March 06, 2023 12:42:05 PM
Discovery does not "work both ways." Each party in the lawsuit must know what to ask for and it must be relevant to the case. Defendants cannot go on a fishing expedition asking for every single piece of paper that's ever come across the eyes of Linda Powers. Nor will NWBO be forced to open their books any further than what's been reported in SEC filings. Discovery only involves evidence that can prove or disprove elements of the case.
Spoofing is the subject of the case not the conspiracy theories put forward by short sellers. Northwest Biotherapeutics isn't vulnerable to discovery in any way since they're not on trial. Nothing Northwest Biotherapeutics did or could ever do would enable or justify Market Makers to engage in criminal behavior. If defendants algorithms are designed to spoof then their intellectual property could be asked for in discovery which explains why they will likely want to settle!
Spoofing is the subject of the case not the conspiracy theories put forward by short sellers. Northwest Biotherapeutics isn't vulnerable to discovery in any way since they're not on trial. Nothing Northwest Biotherapeutics did or could ever do would enable or justify Market Makers to engage in criminal behavior. If defendants algorithms are designed to spoof then their intellectual property could be asked for in discovery which explains why they will likely want to settle!
Bullish
Do your own research. I am not providing legal or investment advice. This is an anonymous forum for entertainment purposes only. Don't trust anything you read.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
